Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Dentsu Group Acquires a Majority Stake in Extentia to Strengthen Customer Transformation and Technology Capabilities 2022-08-04 20:00
Hyundai, Genesis and Kia Sweep Red Dot Awards: Brand & Communications Design 2022 2022-08-04 18:39
Trend Micro Launches New Unified Security Platform to Augment Security Teams in Singapore 2022-08-04 17:04
2022 Fortune Global 500 List Released, With Country Garden Rising to the 138th 2022-08-04 16:59
CHiQ's portable air conditioners now available in Singapore 2022-08-04 16:09
The Adecco Group: Q2 22 Results - Market share momentum, solid growth and margin 2022-08-04 15:28
CK Group's Media Response 2022-08-04 15:04
The Adecco Group: HALF YEAR REPORT 2022 2022-08-04 12:50
OneConnect Financial Technology Announces the Launch of All-In-One Digital Banking Solutions Suite, OneCosmo 2022-08-04 12:44
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA 2022-08-04 08:10
Sun Life Appoints Chris Wei to EVP and Chief Client and Innovation Officer 2022-08-04 05:20
Franklin Templeton, Inc. Renews with Empire State Realty Trust for 79k Square Feet at 100 First Stamford Place 2022-08-04 04:30
PENFOLDS LAUNCH TWO INAUGURAL FRENCH WINES 2022-08-04 04:00
Ping An Ranks 25th in the Fortune Global 500 List, 1st among mixed-ownership Chinese enterprises 2022-08-03 21:44
China Literature to Report First Half 2022 Financial Results on August 15, 2022 2022-08-03 21:15
Autohome 2022 Q2 Revenues Beats Consensus, Sustains Strong Recovery Momentum, Posts Excellent Profitability 2022-08-03 19:39
Airtel awards its first 5G contract in India to Ericsson 2022-08-03 18:52
MARRIOTT INTERNATIONAL SIGNS MEMORANDUM OF UNDERSTANDING (MOU) WITH THE MINISTRY OF TOURISM AND CREATIVE ECONOMY OF THE REPUBLIC OF INDONESIA 2022-08-03 18:00
Hisense Shines in UEFA Women's EURO 2022™, Achieved Champion Position in Global Market 2022-08-03 17:32
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients 2022-08-03 16:50
1 304 305 306 307 308 1079